Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30 | -60 | 100 | 153 | N/A |
| Depreciation Amortization | 31 | 26 | 28 | 20 | N/A |
| Accounts receivable | 463 | -701 | 2,150 | -2,170 | N/A |
| Accounts payable and accrued liabilities | -490 | 464 | -924 | 963 | N/A |
| Other Working Capital | 97 | -200 | 1,227 | -901 | N/A |
| Other Operating Activity | 46 | 255 | -1,218 | 1,267 | 0 |
| Operating Cash Flow | $117 | $-216 | $1,363 | $-669 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -39 | -26 | -24 | N/A |
| Other Investing Activity | 6 | -9 | 5 | 6 | 0 |
| Investing Cash Flow | $-26 | $-48 | $-22 | $-18 | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Beginning Cash Position | 2,360 | 2,623 | 1,281 | 1,968 | N/A |
| End Cash Position | 2,450 | 2,360 | 2,623 | 1,281 | N/A |
| Net Cash Flow | $91 | $-264 | $1,342 | $-687 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 117 | -216 | 1,363 | -669 | N/A |
| Capital Expenditure | -32 | -39 | -26 | -24 | N/A |
| Free Cash Flow | 85 | -255 | 1,337 | -694 | 0 |